Trends in therapy and prophylaxis 1991-2001

Bulletin of the European Association of Fish Pathologists

Volumn 22, Issue 2, 2002, Pages 117-125

  Alderman, D J ^a  

^a CENTRE FOR ENVIRONMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0348000781     PISSN: 01080288     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Advisory Committee on the Microbial Safety of Food (1999). Chapter 11 Aquaculture and Annex F. In: Report on microbial antibiotic resistance in relation to food safety. Her Majesty's Stationary Office, 320pp.
2. Alderman, D.J. (1999). Requirements for the approval of veterinary therapeutics or growth enhancers in fish production: European Union. Chapter 3 in Smith, D.J., Gingerich, W.H. and Beconi-Barker, M.G. (Eds.) Xenobiotics in Fish, American Chemical Society Symposium, Dallas, Texas, April 1998. Pp 25-38. Kluwer / Plenum Press, New York.
3. Alderman D.J., and Hastings T.S. 1998. Antibiotic use in aquaculture: development of antibiotic resistance - potential for consumer health risks. Int. J Food Sci. Tech 33, 139-155.
4. Barnes, A C, Lewin, C S, Hastings, T S and Amyes, SGB (1990). Cross-resistance between oxytetracycline and oxolinic acid in Aeromonas salmonicida associated with alterations in outer membrane proteins. FEMS Microbiology Letters 72, 337-340.
5. Bjorklund, H V, Rabergh, C M I and Bylund, G (1991). Residues of oxolinic acid and oxytetracycline in fish and sediments from fish farms. Aquaculture 97, 85-96.
6. Committee for Veterinary Medicinal Products (1997). Note for guidance on the establishment of maximum residue limits for minor species. EMEA/CVMP/153a/97-FINAL. 6pp. European Medicines Evaluation Agency, Veterinary Medicines Evaluation Unit, London.
7. Committee for Veterinary Medicinal Products (1998). Note for guidance on the establishment of maximum residue limits for Salmonidae and other fin fish. EMEA/ CVMP/153b/97-FINAL. 2pp. European Medicines Evaluation Agency, Veterinary Medicines Evaluation Unit, London.
8. Council of the European Communities (1981a). Council Directive No. 81/851/EEC on the approximation of the laws of Member States relating to veterinary medicinal products. Official Journal of the European Communities, L317, 1-15
9. Council of the European Communities (1981b). Council Directive No. 81/852/EEC on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of testing of veterinary medicinal products. Official Journal of the European Communities, L317, 16-28.
10. Council of the European Communities (1987). Council Directive No. 87/20/EEC amending Directive 81/852/EEC on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of testing of veterinary medicinal products. Official Journal of the European Communities L15, 34-35.
11. Council of the European Communities (1990). Council Regulation No. 2377/90/EEC laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Official Journal of the European Communities L224, 1-8).
12. Council of the European Communities (1996). Council Directive No. 96/23/EC on measures to monitor certain substances and residues thereof in live animals and animal products and repealing Directives 85/358/EEC and 86/ 469/EEC and Decisions 89/187/EEC and 91/ 664/EEC. Official Journal of the European Communities L125, 10-32.
13. Council of the European Communities (2001). Commission Directive 2001/79/EC of 17 September 2001 amending Council Directive 87/ 153/EEC fixing guidelines for the assessment of additives in animal nutrition (Text with EEA relevance. Official Journal of the European Communities L267, 1-26.
14. Coyne, R, Hiney, M, O'Connor, B, Kerry, J, Cazabon, D and Smith, P (1994). Concentration and persistence of oxytetracycline in sediments under a marine salmon farm. Aquacult., 123, 31-42.
15. Hastings, T S (1997). Chemotherapy of furunculosis. In Furunculosis: Multidisciplinary Fish Disease Research (E-M Bernoth, ed.) pp. 423-432. Academic Press, London.
16. Husevag, B and Lunestad, B T (1995). Presence of the fish pathogen Aeromonas salmonicida and bacteria resistant to antimicrobial agents in sediments from Norwegian fish farms. Bull. Eur. Ass. Fish Pathol., 15, 17-19.
17. Inglis, V, Frerichs, G N, Millar, S D and Richards, R H (1991). Antibiotic resistance of Aeromonas salmonicida isolated from Atlantic salmon, Salmo salar L, in Scotland. J. Fish Dis., 14, 353-358.
18. Inglis, V, Yimer, E, Bacon, E J and Ferguson, S (1993). Plasmid-mediated antibiotic resistance in Aeromonas salmonicida isolated from Atlantic salmon, Salmo salar L, in Scotland. J. Fisli Dis., 16, 593-600.
19. Kerry, J, Hiney, M, Coyne, R, Cazabon, D, NicGabhainn, S and Smith, P (1994). Frequency and distribution of resistance to oxytetracycline in micro-organisms isolated from marine fish farm sediments following therapeutic use of oxytetracycline. Aquacult., 123, 43-44.
20. Michel C and Alderman, D.J. (eds.). Chemotherapy in Aquaculture Today. Paris: Office International des Epizooties, 567pp.
21. Samuelsen, O B, Lunestad, T, Husevag, B, Holleland, T and Ervik, A (1992a). Residues of oxolinic acid in wild fauna following medication in fish farms. Dis. Aquat. Org. 12, 111-119.
22. Samuelsen, O B, Torsvik, V and Ervik, A (1992b). Long range changes in oxytetracycline concentration and bacterial resistance towards oxytetracycline in fish farm sediment after medication. Sci. Total Envir. 114, 25-36.
23. Smith, P. (1996). Is sediment deposition the dominant fate of oxytetracycline used in marine salmon farms: a review of available evidence. Aquacult., 146, 157-169.
24. Smith, P, Hiney, M P and Samuelsen, O B (1994). Bacterial resistance to antimicrobial agents used in fish farming: a critical evaluation of method and meaning. Ann. Rev. Fish Dis., 4, 273-313.
25. Smith, P, Pursell, L, McCormack, F, O'Reilly, A and Hiney, M (1995). On the significance of bacterial resistance to oxytetracycline in sediments under Norwegian fish farms. Bull. Eur. Ass. Fish Pathol., 15, 105-106.
26. Smith, P, Niland, T, O'Domhnaill, F, O'Tuathaigh, G and Hiney, M (1996). Influence of marine sediment and divalent cations on the activity of oxytetracycline against Listonella anguillarum. Bull. Eur. Ass. Fish Pathol., 16, 54-57.
27. Tsoumas, A, Alderman, D J and Rodgers, C J (1989). Aeromonas salmonicida: development of resistance to 4-quinolone antimicrobials. J. Fish Dis. 12, 493-507.
28. Veterinary Medicines Directorate (1996). Ecotoxicity testing of medicines intended for use in fish farming. Animal Medicines European Licensing Information and Advice (AMELIA) 11, 36pp.
29. Veterinary Medicines Directorate (2001). Residues, controls and monitoring, Medicines Act Veterinary Information Service 40, 11-12.
30. World Health Organisation of the United Nations (1999). Food safety issues associated with products from aquaculture. Report of a Joint FAO/NACA/WHO Study Group. WHO Technical Report Series 883, 55pp.
31. United States Food and Drug Administration. (1998). Proposals to increase the legal availability of animal drugs for minor species and minor uses. Report of ADAA Minor use / minor species working group. Docket No. 97N-0217, Federal Register 63 FR 58056 10/29/98.